Generally, the early screening and diagnosis of AFP-negative HCC patients tend to rely heavily on imaging examinations, such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI). The gene discussed is AFP; the disease is hepatocellular carcinoma.